Tute Genomics, a Utah-based company founded in 2012, is at the forefront of genomic innovation. The company's mission is to revolutionize healthcare by leveraging cloud-based solutions for precision genome-guided medicine. With a focus on biotechnology and healthcare, Tute Genomics is harnessing the power of genomics to personalize treatment, unlock the genome, and drive groundbreaking discoveries. Their recent Series A investment of $3.90M on 16 June 2015 attracted notable investors including Healthbox, Eurovestech, Tencent, and Intermountain Healthcare. Tute Genomics stands as a promising player in the genomics industry, poised to shape the future of medicine through innovation and strategic partnerships.
No recent news or press coverage available for Tute Genomics.